Filing Details
- Accession Number:
- 0001562180-21-001945
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 19:14:49
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 19:14:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636422 | Health Catalyst Inc. | HCAT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1494174 | H. Daniel Orenstein | C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-01 | 733 | $48.60 | 82,313 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-03-01 | 23 | $49.63 | 82,290 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-03-02 | 1,744 | $47.52 | 80,546 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- Represents the weighted average sale price of the shares sold ranging from $48.15 to $49.06 per share, inclusive.
- Represents the weighted average sale price of the shares sold ranging from $49.17 to $49.93 per share, inclusive.
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2020, in accordance with Rule 10b5-1.
- Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $47.21 to $48.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2), (3), and (5).
Billionaire Hedge Funds
